Share Price and Basic Stock Data
Last Updated: February 10, 2026, 10:07 pm
| PEG Ratio | 1.16 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
CCL International Ltd operates in the Trading & Distributors sector and reported a market capitalization of ₹48.8 Cr. The company’s share price stood at ₹25.4, reflecting a price-to-earnings ratio (P/E) of 28.0. Over the past years, CCL has experienced significant fluctuations in its revenue. For instance, sales were recorded at ₹14.35 Cr in FY 2023, a decline from ₹26.80 Cr in FY 2022. However, the company rebounded in FY 2024, reporting sales of ₹32.22 Cr, and is projected to reach ₹44.69 Cr in FY 2025. Quarterly sales have also shown variability; for instance, the highest quarterly sales of ₹16.31 Cr occurred in March 2024, while the lowest was merely ₹0.06 Cr in December 2022. This volatility indicates a potential dependency on specific market conditions or product cycles, which may pose risks but also present opportunities for recovery and growth.
Profitability and Efficiency Metrics
CCL International Ltd’s profitability metrics reveal a challenging landscape. The company recorded a net profit of ₹1.74 Cr, reflecting a low return on equity (ROE) of 1.47% and a return on capital employed (ROCE) of 3.35%. Operating profit margins (OPM) have varied considerably, standing at -0.20% overall, with quarterly OPM fluctuating between -108.70% in September 2024 and a high of 17.16% in March 2023. This inconsistency in profitability metrics raises concerns over operational efficiency. The interest coverage ratio (ICR) was reported at 3.95x, indicating that the company can cover its interest obligations comfortably, yet its OPM and net profit margins remain substantially lower than typical sector averages. Such figures suggest that while CCL is managing its debt, it struggles to convert sales into profits efficiently, which could hinder long-term sustainability and investor confidence.
Balance Sheet Strength and Financial Ratios
The balance sheet of CCL International Ltd indicates moderate financial health, with total assets reported at ₹75.46 Cr and total liabilities at ₹75.46 Cr as of FY 2025. The company’s reserves stood at ₹28.08 Cr, while borrowings were recorded at ₹14.41 Cr, resulting in a manageable debt-to-equity ratio. The price-to-book value (P/BV) ratio was noted at 0.43x, suggesting that the stock is trading below its book value, which may attract value investors. However, the cash conversion cycle (CCC) of 110.18 days reflects inefficiencies in converting inventory and receivables into cash. Additionally, the current ratio indicates liquidity strength at 1.93x, which is above the typical benchmark of 1.5, providing a cushion for short-term obligations. Overall, while the equity structure appears stable, the high CCC and low profitability ratios highlight areas requiring management attention to improve operational efficiency.
Shareholding Pattern and Investor Confidence
The shareholding structure of CCL International Ltd reveals a strong promoter commitment, with promoters holding 63.85% of the equity as of March 2025. This high level of promoter ownership can instill confidence among investors regarding the company’s governance and strategic direction. However, foreign institutional investors (FIIs) hold a negligible 0.01%, indicating limited external institutional interest, which may reflect concerns over the company’s financial performance or market positioning. The public holding stood at 36.13%, with a total of 3,086 shareholders, suggesting a relatively engaged retail investor base. The gradual increase in the number of shareholders from 2,291 in December 2022 to the current figure indicates growing interest, although the lack of institutional backing could pose risks to liquidity and stock price stability. This mixed ownership profile may impact investor sentiment and the company’s ability to attract further investment.
Outlook, Risks, and Final Insight
CCL International Ltd faces both opportunities and challenges moving forward. The recent recovery in sales and operating profits suggests potential for growth, particularly if management can address the inefficiencies highlighted in the cash conversion cycle and profitability metrics. However, the company’s reliance on a limited revenue stream and high operational variability poses significant risks. Additionally, the negligible foreign institutional investment might hinder its ability to leverage broader market opportunities. Investors should closely monitor the company’s strategic initiatives aimed at improving operational efficiencies and profitability. If CCL can successfully navigate these challenges, there may be a favorable outlook for future performance. Conversely, continued underperformance in profitability and reliance on a concentrated shareholder base could limit its growth trajectory. Overall, CCL’s future hinges on its ability to enhance operational efficiency and attract broader investor interest.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Millennium Online Solutions (India) Ltd | 8.00 Cr. | 1.60 | 2.88/1.36 | 0.81 | 0.00 % | 4.61 % | 5.54 % | 1.00 | |
| Minal Industries Ltd | 54.1 Cr. | 2.82 | 5.59/2.50 | 36.1 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 12.1 Cr. | 13.8 | 17.8/11.5 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 | |
| Modella Woollens Ltd | 5.77 Cr. | 63.5 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 145 Cr. | 46.3 | 54.5/10.2 | 161 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| Industry Average | 9,176.55 Cr | 155.26 | 104.58 | 120.60 | 0.40% | 15.22% | 8.81% | 7.62 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.07 | 0.06 | 8.74 | 5.68 | 3.26 | 10.45 | 16.31 | 6.84 | 0.46 | 2.52 | 36.01 | 8.60 | 5.06 |
| Expenses | 4.44 | 1.91 | 7.24 | 4.79 | 2.88 | 9.37 | 14.00 | 5.87 | 0.96 | 3.13 | 31.37 | 7.53 | 5.07 |
| Operating Profit | 0.63 | -1.85 | 1.50 | 0.89 | 0.38 | 1.08 | 2.31 | 0.97 | -0.50 | -0.61 | 4.64 | 1.07 | -0.01 |
| OPM % | 12.43% | -3,083.33% | 17.16% | 15.67% | 11.66% | 10.33% | 14.16% | 14.18% | -108.70% | -24.21% | 12.89% | 12.44% | -0.20% |
| Other Income | 0.07 | 0.14 | 0.07 | 0.08 | 0.35 | 0.47 | 0.16 | 0.10 | 0.12 | 0.12 | 0.25 | 0.46 | 0.17 |
| Interest | 0.14 | 0.22 | 0.26 | 0.20 | 0.13 | 0.33 | 1.23 | 0.25 | 0.18 | 0.17 | 0.89 | 0.37 | 0.11 |
| Depreciation | 0.55 | 0.74 | 0.63 | 0.67 | 0.60 | 0.82 | 0.76 | 0.66 | 0.66 | 0.68 | 0.68 | 0.62 | 0.64 |
| Profit before tax | 0.01 | -2.67 | 0.68 | 0.10 | -0.00 | 0.40 | 0.48 | 0.16 | -1.22 | -1.34 | 3.32 | 0.54 | -0.59 |
| Tax % | -100.00% | -27.34% | 23.53% | -20.00% | -2.50% | -95.83% | 12.50% | -4.92% | -0.75% | 8.43% | -5.56% | -3.39% | |
| Net Profit | 0.01 | -1.94 | 0.52 | 0.11 | -0.00 | 0.41 | 0.95 | 0.15 | -1.16 | -1.32 | 3.05 | 0.57 | -0.56 |
| EPS in Rs | 0.01 | -1.01 | 0.27 | 0.06 | -0.00 | 0.21 | 0.49 | 0.08 | -0.60 | -0.69 | 1.59 | 0.30 | -0.29 |
Last Updated: February 2, 2026, 5:16 pm
Below is a detailed analysis of the quarterly data for CCL International Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 5.06 Cr.. The value appears to be declining and may need further review. It has decreased from 8.60 Cr. (Jun 2025) to 5.06 Cr., marking a decrease of 3.54 Cr..
- For Expenses, as of Sep 2025, the value is 5.07 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.53 Cr. (Jun 2025) to 5.07 Cr., marking a decrease of 2.46 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 1.07 Cr. (Jun 2025) to -0.01 Cr., marking a decrease of 1.08 Cr..
- For OPM %, as of Sep 2025, the value is -0.20%. The value appears to be declining and may need further review. It has decreased from 12.44% (Jun 2025) to -0.20%, marking a decrease of 12.64%.
- For Other Income, as of Sep 2025, the value is 0.17 Cr.. The value appears to be declining and may need further review. It has decreased from 0.46 Cr. (Jun 2025) to 0.17 Cr., marking a decrease of 0.29 Cr..
- For Interest, as of Sep 2025, the value is 0.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.37 Cr. (Jun 2025) to 0.11 Cr., marking a decrease of 0.26 Cr..
- For Depreciation, as of Sep 2025, the value is 0.64 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.62 Cr. (Jun 2025) to 0.64 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.59 Cr.. The value appears to be declining and may need further review. It has decreased from 0.54 Cr. (Jun 2025) to -0.59 Cr., marking a decrease of 1.13 Cr..
- For Tax %, as of Sep 2025, the value is -3.39%. The value appears to be increasing, which may not be favorable. It has increased from -5.56% (Jun 2025) to -3.39%, marking an increase of 2.17%.
- For Net Profit, as of Sep 2025, the value is -0.56 Cr.. The value appears to be declining and may need further review. It has decreased from 0.57 Cr. (Jun 2025) to -0.56 Cr., marking a decrease of 1.13 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.29. The value appears to be declining and may need further review. It has decreased from 0.30 (Jun 2025) to -0.29, marking a decrease of 0.59.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:00 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 78.36 | 92.63 | 75.81 | 64.08 | 33.22 | 37.11 | 24.80 | 30.08 | 26.80 | 14.35 | 32.22 | 44.69 | 52.19 |
| Expenses | 75.76 | 89.11 | 72.05 | 63.85 | 29.08 | 32.29 | 22.60 | 26.14 | 23.65 | 13.96 | 27.57 | 40.18 | 47.10 |
| Operating Profit | 2.60 | 3.52 | 3.76 | 0.23 | 4.14 | 4.82 | 2.20 | 3.94 | 3.15 | 0.39 | 4.65 | 4.51 | 5.09 |
| OPM % | 3.32% | 3.80% | 4.96% | 0.36% | 12.46% | 12.99% | 8.87% | 13.10% | 11.75% | 2.72% | 14.43% | 10.09% | 9.75% |
| Other Income | 0.59 | 0.58 | 0.39 | 5.59 | -0.57 | 1.23 | 4.40 | 0.34 | 0.99 | 0.87 | 1.07 | 0.59 | 1.00 |
| Interest | 0.66 | 1.31 | 1.63 | 1.44 | 1.55 | 1.53 | 1.90 | 1.01 | 1.00 | 0.76 | 1.89 | 1.49 | 1.54 |
| Depreciation | 1.13 | 1.28 | 1.27 | 1.43 | 1.82 | 2.30 | 2.51 | 2.62 | 2.56 | 2.47 | 2.85 | 2.68 | 2.62 |
| Profit before tax | 1.40 | 1.51 | 1.25 | 2.95 | 0.20 | 2.22 | 2.19 | 0.65 | 0.58 | -1.97 | 0.98 | 0.93 | 1.93 |
| Tax % | 28.57% | 31.79% | 32.00% | -5.08% | 55.00% | 9.46% | 2.28% | 26.15% | 3.45% | -29.95% | -50.00% | 23.66% | |
| Net Profit | 0.99 | 1.03 | 0.85 | 3.10 | 0.08 | 2.01 | 2.14 | 0.48 | 0.57 | -1.39 | 1.47 | 0.72 | 1.74 |
| EPS in Rs | 0.52 | 0.54 | 0.44 | 1.62 | 0.04 | 1.05 | 1.12 | 0.25 | 0.30 | -0.72 | 0.77 | 0.38 | 0.91 |
| Dividend Payout % | 48.46% | 46.58% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 4.04% | -17.48% | 264.71% | -97.42% | 2412.50% | 6.47% | -77.57% | 18.75% | -343.86% | 205.76% | -51.02% |
| Change in YoY Net Profit Growth (%) | 0.00% | -21.52% | 282.18% | -362.13% | 2509.92% | -2406.03% | -84.04% | 96.32% | -362.61% | 549.62% | -256.78% |
CCL International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | 13% |
| 3 Years: | 20% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | 20% |
| 3 Years: | 82% |
| TTM: | -25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -18% |
| 5 Years: | 19% |
| 3 Years: | 19% |
| 1 Year: | 2% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 2:51 pm
Balance Sheet
Last Updated: December 10, 2025, 4:02 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 19.19 | 19.19 | 19.19 | 19.19 | 19.19 | 19.19 | 19.19 | 19.19 | 19.19 | 19.19 | 19.19 | 19.19 | 19.19 |
| Reserves | 16.75 | 17.69 | 19.10 | 22.20 | 22.28 | 24.14 | 26.23 | 26.71 | 27.28 | 25.89 | 27.36 | 28.07 | 28.08 |
| Borrowings | 13.00 | 10.38 | 12.21 | 13.59 | 12.98 | 20.90 | 17.34 | 9.10 | 13.52 | 14.50 | 24.38 | 24.05 | 14.41 |
| Other Liabilities | 20.78 | 15.94 | 12.88 | 16.34 | 10.56 | 5.15 | 7.93 | 6.55 | 6.04 | 2.43 | 3.32 | 4.15 | 2.37 |
| Total Liabilities | 69.72 | 63.20 | 63.38 | 71.32 | 65.01 | 69.38 | 70.69 | 61.55 | 66.03 | 62.01 | 74.25 | 75.46 | 64.05 |
| Fixed Assets | 18.86 | 21.24 | 20.62 | 23.34 | 22.75 | 24.46 | 23.39 | 21.48 | 18.56 | 17.20 | 18.44 | 16.95 | 15.77 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 4.31 | 4.91 | 4.03 | 3.27 | 3.27 | 3.66 | 0.93 | 0.94 | 1.31 | 1.32 | 1.02 | 1.02 | 1.02 |
| Other Assets | 46.55 | 37.05 | 38.73 | 44.71 | 38.99 | 41.26 | 46.37 | 39.13 | 46.16 | 43.49 | 54.79 | 57.49 | 47.26 |
| Total Assets | 69.72 | 63.20 | 63.38 | 71.32 | 65.01 | 69.38 | 70.69 | 61.55 | 66.03 | 62.01 | 74.25 | 75.46 | 64.05 |
Below is a detailed analysis of the balance sheet data for CCL International Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 19.19 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.19 Cr..
- For Reserves, as of Sep 2025, the value is 28.08 Cr.. The value appears strong and on an upward trend. It has increased from 28.07 Cr. (Mar 2025) to 28.08 Cr., marking an increase of 0.01 Cr..
- For Borrowings, as of Sep 2025, the value is 14.41 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 24.05 Cr. (Mar 2025) to 14.41 Cr., marking a decrease of 9.64 Cr..
- For Other Liabilities, as of Sep 2025, the value is 2.37 Cr.. The value appears to be improving (decreasing). It has decreased from 4.15 Cr. (Mar 2025) to 2.37 Cr., marking a decrease of 1.78 Cr..
- For Total Liabilities, as of Sep 2025, the value is 64.05 Cr.. The value appears to be improving (decreasing). It has decreased from 75.46 Cr. (Mar 2025) to 64.05 Cr., marking a decrease of 11.41 Cr..
- For Fixed Assets, as of Sep 2025, the value is 15.77 Cr.. The value appears to be declining and may need further review. It has decreased from 16.95 Cr. (Mar 2025) to 15.77 Cr., marking a decrease of 1.18 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 1.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.02 Cr..
- For Other Assets, as of Sep 2025, the value is 47.26 Cr.. The value appears to be declining and may need further review. It has decreased from 57.49 Cr. (Mar 2025) to 47.26 Cr., marking a decrease of 10.23 Cr..
- For Total Assets, as of Sep 2025, the value is 64.05 Cr.. The value appears to be declining and may need further review. It has decreased from 75.46 Cr. (Mar 2025) to 64.05 Cr., marking a decrease of 11.41 Cr..
Notably, the Reserves (28.08 Cr.) exceed the Borrowings (14.41 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -10.40 | -6.86 | -8.45 | -13.36 | -8.84 | -16.08 | -15.14 | -5.16 | -10.37 | -14.11 | -19.73 | -19.54 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 55.57 | 6.23 | 66.59 | 66.81 | 79.11 | 109.27 | 251.38 | 112.97 | 272.52 | 207.30 | 182.61 | 110.18 |
| Inventory Days | 67.61 | 68.61 | 63.26 | 123.89 | 131.56 | 104.55 | 145.93 | 99.74 | 84.97 | |||
| Days Payable | 109.87 | 65.19 | 71.94 | 83.47 | 112.29 | 24.76 | 76.59 | 52.96 | 57.23 | |||
| Cash Conversion Cycle | 13.31 | 9.65 | 57.91 | 107.23 | 98.39 | 189.06 | 320.71 | 159.75 | 300.27 | 207.30 | 182.61 | 110.18 |
| Working Capital Days | 2.98 | 6.97 | 40.25 | 51.09 | 109.87 | 135.93 | 270.81 | 242.32 | 330.00 | 613.00 | 246.51 | 182.21 |
| ROCE % | 4.54% | 5.86% | 5.89% | -1.06% | 5.67% | 5.71% | 0.41% | 2.84% | 1.83% | -2.96% | 3.59% | 3.35% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 19 | Mar 18 | Mar 17 |
|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.07 | 0.36 | 1.60 |
| Diluted EPS (Rs.) | 1.07 | 0.36 | 1.60 |
| Cash EPS (Rs.) | 2.24 | 0.99 | 2.36 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 22.45 | 21.46 | 21.09 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 22.45 | 21.46 | 21.09 |
| Revenue From Operations / Share (Rs.) | 19.33 | 17.31 | 34.07 |
| PBDIT / Share (Rs.) | 3.15 | 1.86 | 3.03 |
| PBIT / Share (Rs.) | 1.96 | 0.91 | 2.29 |
| PBT / Share (Rs.) | 1.16 | 0.10 | 1.54 |
| Net Profit / Share (Rs.) | 1.05 | 0.04 | 1.62 |
| NP After MI And SOA / Share (Rs.) | 1.07 | 0.36 | 1.60 |
| PBDIT Margin (%) | 16.31 | 10.74 | 8.89 |
| PBIT Margin (%) | 10.11 | 5.26 | 6.71 |
| PBT Margin (%) | 5.98 | 0.59 | 4.51 |
| Net Profit Margin (%) | 5.41 | 0.25 | 4.74 |
| NP After MI And SOA Margin (%) | 5.53 | 2.10 | 4.69 |
| Return on Networth / Equity (%) | 4.76 | 1.69 | 7.57 |
| Return on Capital Employeed (%) | 7.85 | 3.81 | 10.57 |
| Return On Assets (%) | 2.97 | 1.07 | 4.35 |
| Long Term Debt / Equity (X) | 0.09 | 0.09 | 0.01 |
| Total Debt / Equity (X) | 0.39 | 0.25 | 0.24 |
| Asset Turnover Ratio (%) | 0.55 | 0.49 | 0.00 |
| Current Ratio (X) | 1.93 | 2.06 | 1.53 |
| Quick Ratio (X) | 1.53 | 1.56 | 1.01 |
| Interest Coverage Ratio (X) | 3.95 | 2.30 | 4.05 |
| Interest Coverage Ratio (Post Tax) (X) | 2.31 | 1.05 | 3.16 |
| Enterprise Value (Cr.) | 29.52 | 25.01 | 43.79 |
| EV / Net Operating Revenue (X) | 0.79 | 0.75 | 0.66 |
| EV / EBITDA (X) | 4.88 | 7.00 | 7.53 |
| MarketCap / Net Operating Revenue (X) | 0.50 | 0.73 | 0.61 |
| Price / BV (X) | 0.43 | 0.58 | 0.99 |
| Price / Net Operating Revenue (X) | 0.50 | 0.73 | 0.61 |
| EarningsYield | 0.11 | 0.02 | 0.07 |
After reviewing the key financial ratios for CCL International Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 19, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 18) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 19, the value is 1.07. This value is below the healthy minimum of 5. It has increased from 0.36 (Mar 18) to 1.07, marking an increase of 0.71.
- For Diluted EPS (Rs.), as of Mar 19, the value is 1.07. This value is below the healthy minimum of 5. It has increased from 0.36 (Mar 18) to 1.07, marking an increase of 0.71.
- For Cash EPS (Rs.), as of Mar 19, the value is 2.24. This value is below the healthy minimum of 3. It has increased from 0.99 (Mar 18) to 2.24, marking an increase of 1.25.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 22.45. It has increased from 21.46 (Mar 18) to 22.45, marking an increase of 0.99.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 22.45. It has increased from 21.46 (Mar 18) to 22.45, marking an increase of 0.99.
- For Revenue From Operations / Share (Rs.), as of Mar 19, the value is 19.33. It has increased from 17.31 (Mar 18) to 19.33, marking an increase of 2.02.
- For PBDIT / Share (Rs.), as of Mar 19, the value is 3.15. This value is within the healthy range. It has increased from 1.86 (Mar 18) to 3.15, marking an increase of 1.29.
- For PBIT / Share (Rs.), as of Mar 19, the value is 1.96. This value is within the healthy range. It has increased from 0.91 (Mar 18) to 1.96, marking an increase of 1.05.
- For PBT / Share (Rs.), as of Mar 19, the value is 1.16. This value is within the healthy range. It has increased from 0.10 (Mar 18) to 1.16, marking an increase of 1.06.
- For Net Profit / Share (Rs.), as of Mar 19, the value is 1.05. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 18) to 1.05, marking an increase of 1.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 19, the value is 1.07. This value is below the healthy minimum of 2. It has increased from 0.36 (Mar 18) to 1.07, marking an increase of 0.71.
- For PBDIT Margin (%), as of Mar 19, the value is 16.31. This value is within the healthy range. It has increased from 10.74 (Mar 18) to 16.31, marking an increase of 5.57.
- For PBIT Margin (%), as of Mar 19, the value is 10.11. This value is within the healthy range. It has increased from 5.26 (Mar 18) to 10.11, marking an increase of 4.85.
- For PBT Margin (%), as of Mar 19, the value is 5.98. This value is below the healthy minimum of 10. It has increased from 0.59 (Mar 18) to 5.98, marking an increase of 5.39.
- For Net Profit Margin (%), as of Mar 19, the value is 5.41. This value is within the healthy range. It has increased from 0.25 (Mar 18) to 5.41, marking an increase of 5.16.
- For NP After MI And SOA Margin (%), as of Mar 19, the value is 5.53. This value is below the healthy minimum of 8. It has increased from 2.10 (Mar 18) to 5.53, marking an increase of 3.43.
- For Return on Networth / Equity (%), as of Mar 19, the value is 4.76. This value is below the healthy minimum of 15. It has increased from 1.69 (Mar 18) to 4.76, marking an increase of 3.07.
- For Return on Capital Employeed (%), as of Mar 19, the value is 7.85. This value is below the healthy minimum of 10. It has increased from 3.81 (Mar 18) to 7.85, marking an increase of 4.04.
- For Return On Assets (%), as of Mar 19, the value is 2.97. This value is below the healthy minimum of 5. It has increased from 1.07 (Mar 18) to 2.97, marking an increase of 1.90.
- For Long Term Debt / Equity (X), as of Mar 19, the value is 0.09. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 18) which recorded 0.09.
- For Total Debt / Equity (X), as of Mar 19, the value is 0.39. This value is within the healthy range. It has increased from 0.25 (Mar 18) to 0.39, marking an increase of 0.14.
- For Asset Turnover Ratio (%), as of Mar 19, the value is 0.55. It has increased from 0.49 (Mar 18) to 0.55, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 19, the value is 1.93. This value is within the healthy range. It has decreased from 2.06 (Mar 18) to 1.93, marking a decrease of 0.13.
- For Quick Ratio (X), as of Mar 19, the value is 1.53. This value is within the healthy range. It has decreased from 1.56 (Mar 18) to 1.53, marking a decrease of 0.03.
- For Interest Coverage Ratio (X), as of Mar 19, the value is 3.95. This value is within the healthy range. It has increased from 2.30 (Mar 18) to 3.95, marking an increase of 1.65.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 19, the value is 2.31. This value is below the healthy minimum of 3. It has increased from 1.05 (Mar 18) to 2.31, marking an increase of 1.26.
- For Enterprise Value (Cr.), as of Mar 19, the value is 29.52. It has increased from 25.01 (Mar 18) to 29.52, marking an increase of 4.51.
- For EV / Net Operating Revenue (X), as of Mar 19, the value is 0.79. This value is below the healthy minimum of 1. It has increased from 0.75 (Mar 18) to 0.79, marking an increase of 0.04.
- For EV / EBITDA (X), as of Mar 19, the value is 4.88. This value is below the healthy minimum of 5. It has decreased from 7.00 (Mar 18) to 4.88, marking a decrease of 2.12.
- For MarketCap / Net Operating Revenue (X), as of Mar 19, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 0.73 (Mar 18) to 0.50, marking a decrease of 0.23.
- For Price / BV (X), as of Mar 19, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 18) to 0.43, marking a decrease of 0.15.
- For Price / Net Operating Revenue (X), as of Mar 19, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 0.73 (Mar 18) to 0.50, marking a decrease of 0.23.
- For EarningsYield, as of Mar 19, the value is 0.11. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 18) to 0.11, marking an increase of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CCL International Ltd:
- Net Profit Margin: 5.41%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 7.85% (Industry Average ROCE: 15.22%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.76% (Industry Average ROE: 8.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.31
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.53
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 28.9 (Industry average Stock P/E: 104.58)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.39
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.41%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | M-4, Gupta Tower, B 1/1, Commercial Complex, New Delhi Delhi 110033 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Akash Gupta | Chairman & Managing Director |
| Mrs. Rama Gupta | Executive Director |
| Mr. Rajni Kant Gupta | Independent Director |
| Mr. Tarun Kumar Gupta | Independent Director |
| Ms. Deepanshi Rajput | Independent Director |
FAQ
What is the intrinsic value of CCL International Ltd?
CCL International Ltd's intrinsic value (as of 10 February 2026) is ₹10.65 which is 59.35% lower the current market price of ₹26.20, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹50.3 Cr. market cap, FY2025-2026 high/low of ₹35.8/21.2, reserves of ₹28.08 Cr, and liabilities of ₹64.05 Cr.
What is the Market Cap of CCL International Ltd?
The Market Cap of CCL International Ltd is 50.3 Cr..
What is the current Stock Price of CCL International Ltd as on 10 February 2026?
The current stock price of CCL International Ltd as on 10 February 2026 is ₹26.2.
What is the High / Low of CCL International Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CCL International Ltd stocks is ₹35.8/21.2.
What is the Stock P/E of CCL International Ltd?
The Stock P/E of CCL International Ltd is 28.9.
What is the Book Value of CCL International Ltd?
The Book Value of CCL International Ltd is 24.6.
What is the Dividend Yield of CCL International Ltd?
The Dividend Yield of CCL International Ltd is 0.00 %.
What is the ROCE of CCL International Ltd?
The ROCE of CCL International Ltd is 3.35 %.
What is the ROE of CCL International Ltd?
The ROE of CCL International Ltd is 1.47 %.
What is the Face Value of CCL International Ltd?
The Face Value of CCL International Ltd is 10.0.